Melatonin and Alzheimer’s Disease: A Mini-Review

키워드

참고문헌 (37)

1. Gong YH, "Melatonin ameliorates Aβ1-42-induced Alzheimer’s cognitive deficits in mouse model", J Pharm Pharmacol, 70, pp.70~80 (2018)
2. Luengo E, "Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux", J Pineal Res, 67, pp.e12578~ (2019)
3. Chen D, "Melatonin directly binds and inhibits death-associated protein kinase 1 function in Alzheimer’s disease", J Pineal Res, 69, pp.e12665~ (2020)
4. Ozansoy M, "Melatonin affects the release of exosomes and tau-content in in vitro amyloid-beta toxicity model", J Clin Neurosci, 73, pp.237~244 (2020)
5. Pappolla MA, "Melatonin treatment enhances Aβ lymphatic clearance in a transgenic mouse model of amyloidosis", Curr Alzheimer Res, 15, pp.637~642 (2018)
6. Li Y, "Melatonin regulates Aβ production", clearance balance and Aβ neurotoxicity : a potential therapeutic molecule for Alzheimer’s disease, 2020, pp.132, 110887~
7. Labban S, "Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease", Behav Brain Res, 402, pp.113100~ (2021)
8. Ansari Dezfouli M, "Melatonin protective effect against amyloid β-induced neurotoxicity mediated by mitochondrial biogenesis; involvement of hippocampal Sirtuin-1 signaling pathway", Physiol Behav, 204, pp.65~75 (2019)
9. Jürgenson M, "Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer’s disease", J Pharm Pharmacol, 71, pp.1695~1705 (2019)
10. Chen BH, "Melatonin attenuates scopolamine-induced cognitive impairment via protecting against demyelination through BDNF-TrkB signaling in the mouse dentate gyrus", Chem Biol Interact, 285, pp.8~13 (2018)
11. Wang P, "Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease", Neural Regen Res, 16, pp.757~764 (2021)
12. Shi Y, "Melatonin in synaptic impairments of Alzheimer’s disease", J Alzheimers Dis, 63, pp.911~926 (2018)
13. Hossain MF, "Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer’s disease neuropathology", Ageing Res Rev, 67, pp.101304~ (2021)
14. Ramezani M, "Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells(BMSC)in a rat model of Alzheimer’s disease", J Chem Neuroanat, 108, pp.101804~ (2020)
15. Nous A, "Melatonin levels in the Alzheimer’s disease continuum : a systematic review", Alzheimers Res Ther, 13, pp.52~ (2021)
16. Chieh-Hsin Lin, "Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease", Clinical Psychopharmacology and Neuroscience, 19(1), pp.135~144 (2021), 대한정신약물학회[DOI]
17. Manni R, "Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity", Sleep Med, 63, pp.122~126 (2019)
18. Spinedi E, "Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders : focus on Alzheimer’s disease and melatonin", Neuroendocrinology, 108, pp.354~364 (2019)
19. Sulkava S, "Melatonin receptor type 1A gene linked to Alzheimer’s disease in old age", Sleep, 41, pp.zsy103~ (2018)
20. Sumsuzzman DM, "Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia : a systematic review and meta-analysis of randomized controlled trials", Neurosci Biobehav Rev, 127, pp.459~473 (2021)
21. Furio AM, "Possible therapeutic value of melatonin in mild cognitive impairment : a retrospective study", J Pineal Res, 43, pp.404~409 (2007)
22. Singer C, "A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease", Sleep, 26, pp.893~901 (2003)
23. Serfaty M, "Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia", Int J Geriatr Psychiatry, 17, pp.1120~1127 (2002)
24. Wu H, "The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer’s disease", Front Neuroendocrinol, 54, pp.100764~ (2019)
25. Song J., "Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis", Mol Neurodegener, 14, pp.28~ (2019)
26. Zisapel N., "New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation", Br J Pharmacol, 175, pp.3190~3199 (2018)
27. Cruz-Aguilar MA, "EEG coherence and power spectra during REM sleep related to melatonin intake in mild-to-moderate Alzheimer's disease : a pilot study", Int J Neurosci (2021)
28. Cruz-Aguilar MA, "Melatonin effects on EEG activity during sleep onset in mild-to-moderate Alzheimer’s disease : a pilot study", J Alzheimers Dis Rep, 2, pp.55~65 (2018)
29. Chen D, "Cellular mechanisms of melatonin : insight from neurodegenerative diseases", Biomolecules, 10, pp.1158~ (2020)
30. Cardinali DP, "Melatonin as a chronobiotic", cytoprotector : its role in healthy aging, 2019, pp.50, 28~45
31. Shen S, "The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer’s disease", Int J Biol Sci, 18, pp.983~994 (2022)
32. Rubio-González A, "Melatonin prevents the harmful effects of obesity on the brain, including at the behavioral level", Mol Neurobiol, 55, pp.5830~5846 (2018)
33. Maher AM, "Exogenous melatonin restrains neuroinflammation in high fat diet induced diabetic rats through attenuating indoleamine 2,3-dioxygenase 1 expression", Life Sci, 247, pp.117427~ (2020)
34. Alzoubi KH, "Melatonin prevents memory impairment induced by high-fat diet : role of oxidative stress", Behav Brain Res, 336, pp.93~98 (2018)
35. Park H, "Activation of melatonin receptor 1 by CRISPRCas9 activator ameliorates cognitive deficits in an Alzheimer’s disease mouse model", J Pineal Res, 72, pp.e12787~ (2022)
36. Yao K, "Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells", Drug Des Devel Ther, 13, pp.387~396 (2019)
37. Tang H, "Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer’s disease via C", EBPα, Aging Cell, pp.2019, 18[DOI]

관련 논문AI추천